Exchange: NYSE·Updated 07:28 PM EDT
ZBH logo

ZBHZimmer Biomet Holdings Inc

$86.09
$5.15
(5.64%)
Today
Closed $86.09
$0.09
(0.10%)
After Hours
EarningsAug 6
Mkt Cap$17.65B
Vol4.14M
News
all
press releases
Pacira To Sell Iovera Business To Zimmer Biomet; Pacira Shares Up
(RTTNews) - Pacira BioSciences Inc. (PCRX) on Tuesday announced an agreement to divest its iovera business to Zimmer Biomet Holdings (ZBH) for up to $140 million...
Nasdaq News: Markets
News Placeholder
More News
News Placeholder
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG stands out over ZBH as stronger revenue growth, rising procedure demand, and expanding AI-driven innovation support better upside in 2026.
Zacks
News Placeholder
Why Zimmer Biomet (ZBH) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Here's Why Zimmer Biomet (ZBH) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
News Placeholder
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
ISRG lifts margins despite tariffs, using scale, cost cuts and da Vinci 5 adoption to offset inflation as 2026 cost pressures build.
Zacks
News Placeholder
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
Globus Medical is riding on musculoskeletal market growth with strong Q1 sales gains, double-digit spine growth, and rising trauma demand across key product lines.
Zacks
News Placeholder
Why Is Perrigo (PRGO) Down 9% Since Last Earnings Report?
Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
News Placeholder
Here's How Financial Strength Remains a Key Advantage for GMED
Globus Medical's debt-free balance sheet, nearly $630M in liquid assets and strong cash flow give it the flexibility to fund growth and support shareholders.
Zacks
News Placeholder
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.
Zacks
News Placeholder
GE HealthCare (GEHC) Up 3.3% Since Last Earnings Report: Can It Continue?
GE HealthCare (GEHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
<
1
2
...
>

Advertisement|Remove ads.